Trial Profile
Randomized controlled trial to investigate the retention time of intravesical instillation therapy with pirarubicin for non-muscule invasive bladder cancer following transurethral resection of bladder tumor.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Pirarubicin (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 12 Dec 2011 New trial record